Petah Tikva News
-
Gazit-Globe Ltd. jumped the most in three months in New York, narrowing its discount to the company’s Tel Aviv-traded shares, on prospects that rental income at the real estate holding company will keep climbing.
-
Cephalon Inc. won an appeals court ruling that could help it block generic versions of the muscle- relaxant Amrix.
-
Teva Pharmaceutical Industries Ltd. is recalling 792,603 asthma inhalers because they failed tests to ensure they had identical contents.
-
Teva Pharmaceutical Industries Ltd. will buy back as much as $1 billion in shares and American depositary receipts over the next 12 months.
-
Teva Pharmaceutical Industries Ltd. is ready for an acquisition the size of last year’s 3.63 billion-euro ($4.9 billion) Ratiopharm GmbH takeover as it aims to boost sales to $31 billion by 2015.
-
Teva Pharmaceutical Industries Ltd. , the world’s biggest maker of generic drugs, sees opportunity in the U.S. health-care overhaul as more people gain insurance coverage in the company’s biggest market.
-
Teva Pharmaceutical Industries Ltd. , the world’s largest maker of generic drugs, said it got a $1.5 billion credit line to refinance debt at more favorable terms.
-
A federal judge said he needs more information on the basis for Bank of America Corp.’s $33 million settlement of a lawsuit filed by the U.S. Securities and Exchange Commission before he can approve it.
-
Teva Pharmaceutical Industries Ltd. , the world’s biggest generic-drug maker, agreed to buy a 57 percent stake in Taiyo Pharmaceutical Industry Co. to benefit from Japan’s push to broaden the use of copycat medicines.
-
Teva Pharmaceutical Industries Ltd. investors may have to brace for more profit disappointments as threats loom over its top drug.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page